Overview

A Safety Study Of Pregabalin In Fibromyalgia

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the safety of pregabalin in patients with fibromyalgia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin
Criteria
Inclusion Criteria:

- Patients must meet the ACR criteria for fibromyalgia (ie, widespread pain present for
at least 3 months, and pain in at least 11 of 18 specific tender point sites.

- Patients must complete the double-blind study.

Exclusion Criteria:

- Patients who experienced a serious adverse event during the previous fibromyalgia
study, which was determined to be related to the study medication.